MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 153 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $55,000 | -59.6% | 44,000 | 0.0% | 0.03% | -61.8% |
| Q1 2017 | $136,000 | -24.4% | 44,000 | 0.0% | 0.08% | -31.5% |
| Q4 2016 | $180,000 | -35.5% | 44,000 | 0.0% | 0.11% | -31.9% |
| Q3 2016 | $279,000 | +17.7% | 44,000 | 0.0% | 0.16% | -5.2% |
| Q2 2016 | $237,000 | -35.6% | 44,000 | 0.0% | 0.17% | -34.4% |
| Q1 2016 | $368,000 | +55.3% | 44,000 | +46.7% | 0.26% | +92.6% |
| Q4 2015 | $237,000 | -34.2% | 30,000 | -29.1% | 0.14% | -41.4% |
| Q3 2015 | $360,000 | -31.2% | 42,300 | 0.0% | 0.23% | -15.9% |
| Q2 2015 | $523,000 | +4.0% | 42,300 | 0.0% | 0.28% | +4.5% |
| Q1 2015 | $503,000 | +5.2% | 42,300 | 0.0% | 0.26% | -5.0% |
| Q4 2014 | $478,000 | – | 42,300 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |